1,8-dihydroxy-3-carboxyl-9,10-anthraquinone, 4,5-dihydroxyanthraquinone-2-carboxylic acid, dipropionyl rhein, rhein
Name | Rhein | ||
PubChem CID | 10168 | ||
Molecular Weight | 284.22g/mol | ||
Synonyms |
1,8-dihydroxy-3-carboxyl-9,10-anthraquinone, 4,5-dihydroxyanthraquinone-2-carboxylic acid, dipropionyl rhein, rhein |
||
Formula | C₁₅H₈O₆ | ||
SMILES | C1=CC2=C(C(=C1)O)C(=O)C3=C(C2=O)C=C(C=C3O)C(=O)O | ||
InChI | 1S/C15H8O6/c16-9-3-1-2-7-11(9)14(19)12-8(13(7)18)4-6(15(20)21)5-10(12)17/h1-5,16-17H,(H,20,21) | ||
InChIKey | FCDLCPWAQCPTKC-UHFFFAOYSA-N | ||
CAS Number | 478-43-3 | ||
ChEMBL ID | CHEMBL418068 | ||
ChEBI ID | CHEBI:8825 | ||
Herb ID | HBIN042199 | ||
Drug Bank ID | DB13174 | ||
KEGG ID | C10401 | ||
Toxicity | Organism | Test Type | Route(Dose) |
rat | LD50 | intraperitoneal(165 mg/kg) | |
mouse | LD50 | intraperitoneal(254 mg/kg) | |
rat | LD50 | oral(322 mg/kg) | |
Structure |
Download
2D
MOL
3D
MOL
|
Chineses Pinyin | HuZhang | ||
Use Part | Rhizome | ||
Habitat | Shaanxi, GanSu, JiangSu, ZheJiang, AnHui, FuJian, JiangXi, ShanDong, ShangHai, HeNan, HuBei, HuNan, SiChuan | ||
Flavor | Mildly bitter | ||
Meridian Tropism | Liver, Gallbladder, Lung | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Caryophyllales
-->Family: Polygonaceae
-->Genus: Persicaria
-->Species: Polygonum cuspidatum
|
Chineses Pinyin | ZhangYeDaHuang | ||
Use Part | Root and rhizome | ||
Habitat | GanSu, SiChuan, QingHai, YunNan, XiZang | ||
Species |
>Kingdom: Viridiplantae
-->Phylum: Streptophyta
-->Class: Equisetopsida
-->Order: Caryophyllales
-->Family: Polygonaceae
-->Genus: Rheum
-->Species: Rheum palmatum
|
Pair Name | Rhein, Oxaliplatin | |||
Partner Name | Oxaliplatin | |||
Disease Info | [ICD-11: 2C10] | Pancreatic cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | AKT1 | hsa207 |
Down-regulation | Expression | PIK3CA | hsa5290 | |
Up-regulation | Expression | ROS1 | hsa6098 | |
In Vitro Model | PANC-1 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0480 |
MIA PaCa-2 | Pancreatic ductal adenocarcinoma | Homo sapiens (Human) | CVCL_0428 | |
Result | These data demonstrate that Rhein can induce apoptosis and enhance the oxaliplatin sensitivity of PC cells, suggesting that Rhein may be an effective strategy to overcome drug resistance in the chemotherapeutic treatment of PC. |
Pair Name | Rhein, Doxorubicin | |||
Partner Name | Doxorubicin | |||
Disease Info | [ICD-11: 2C12] | Hepatocellular carcinoma | Investigative | |
Gene Regulation | Up-regulation | Activity | CASP3 | hsa836 |
In Vitro Model | SMMC-7721 | Human papillomavirus-related cervical adenocarcinoma | Homo sapiens (Human) | CVCL_0534 |
Hep-G2 | Hepatoblastoma | Homo sapiens (Human) | CVCL_0027 | |
Result | Our data indicate that a decline in mitochondrial energy metabolism was responsible for the synergistic antitumor effects of rhein and DOX in hepatocellular carcinoma cells. Reduction of ΔΨm and opening of mPTP inhibited the exchange of ATP/adenosine diphosphate between mitochondrial matrix and cytoplasm is the important mechanism. |
Pair Name | Rhein, Pemetrexed | |||
Partner Name | Pemetrexed | |||
Disease Info | [ICD-11: 2C25] | Lung cancer | Investigative | |
Biological Phenomena | Induction-->Autophagy | |||
Gene Regulation | Down-regulation | Expression | AKT1 | hsa207 |
Up-regulation | Expression | MAP1LC3B | hsa81631 | |
Down-regulation | Expression | MTOR | hsa2475 | |
Down-regulation | Expression | PIK3CA | hsa5290 | |
Up-regulation | Phosphorylation | PRKAA1 | hsa5562 | |
In Vitro Model | A-549 | Lung adenocarcinoma | Homo sapiens (Human) | CVCL_0023 |
Result | Our findings demonstrated that the potential application of rhein as a candidate drug in combination with PTX is promising for treatment of the human lung cancer. |
Pair Name | Rhein, Calphostin c | |||
Partner Name | Calphostin c | |||
Disease Info | [ICD-11: 2B90] | Colon cancer | Investigative | |
Biological Phenomena | Induction-->Apoptosis | |||
Gene Regulation | Down-regulation | Expression | XIAP | hsa331 |
In Vitro Model | HCT 116 | Colon carcinoma | Homo sapiens (Human) | CVCL_0291 |
RKO | Colon carcinoma | Homo sapiens (Human) | CVCL_0504 | |
Result | Data suggest that rottlerin affects mitochondrial function independent of PKC delta, thereby sensitizing cells to TRAIL, and that mitochondria constitute an important target in overcoming inherent resistance to TRAIL in colon carcinomas. |
No. | Title | Href |
---|---|---|
1 | Inhibition of PI3K/AKT signaling via ROS regulation is involved in Rhein-induced apoptosis and enhancement of oxaliplatin sensitivity in pancreatic cancer cells. Int J Biol Sci. 2021 Jan 15;17(2):589-602. doi: 10.7150/ijbs.49514. | Click |
2 | Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells. J Cell Biochem. 2020 Oct;121(10):4009-4021. doi: 10.1002/jcb.27514. | Click |
3 | Organic anion transporters and PI3K-AKT-mTOR pathway mediate the synergistic anticancer effect of pemetrexed and rhein. J Cell Physiol. 2020 Apr;235(4):3309-3319. doi: 10.1002/jcp.29218. | Click |
4 | Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res. 2003 Aug 15;63(16):5118-25. | Click |